Search research articles
Contact Us
Filters
Showing results (171-180 of 206) with videos related to
Page
of 21
Sort By:
Biochemistry
|
October 4, 2022
Kinetic Characterization and Inhibition of <i>Trypanosoma cruzi</i> Hypoxanthine-Guanine Phosphoribosyltransferases
Kayla Glockzin, Demetrios Kostomiris, Yacoba V T Minnow, et al.
Journal of the American Chemical Society
|
January 2, 2025
Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents
Vivek Kumar, Jiyun Zhu, Bala C Chenna, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere
S K Thompson, K H Murthy, B Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease
T D Meek, B D Dayton, B W Metcalf, et al.
Nature
|
January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
T D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2016
Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36
Myles B Poulin, Jessica L Schneck, Rosalie E Matico, et al.
Frontiers in Chemistry
|
July 21, 2022
Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents
Jiyun Zhu, Linfeng Li, Aleksandra Drelich, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1989
Peptide substrates and inhibitors of the HIV-1 protease
M L Moore, W M Bryan, S A Fakhoury, et al.
Bioorganic & Medicinal Chemistry
|
October 9, 2022
The design of protozoan phosphoribosyltransferase inhibitors containing non-charged phosphate mimic residues
Sinan Gai, Kajitha Suthagar, Karl J Shaffer, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
D M Lambert, S R Petteway, C E McDanal, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 206) with videos related to
Sort By:
Page
of 21
Biochemistry
|
October 4, 2022
Kinetic Characterization and Inhibition of <i>Trypanosoma cruzi</i> Hypoxanthine-Guanine Phosphoribosyltransferases
Kayla Glockzin, Demetrios Kostomiris, Yacoba V T Minnow, et al.
Journal of the American Chemical Society
|
January 2, 2025
Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents
Vivek Kumar, Jiyun Zhu, Bala C Chenna, et al.
Journal of Medicinal Chemistry
|
September 16, 1994
Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere
S K Thompson, K H Murthy, B Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease
T D Meek, B D Dayton, B W Metcalf, et al.
Nature
|
January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
T D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2016
Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36
Myles B Poulin, Jessica L Schneck, Rosalie E Matico, et al.
Frontiers in Chemistry
|
July 21, 2022
Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents
Jiyun Zhu, Linfeng Li, Aleksandra Drelich, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1989
Peptide substrates and inhibitors of the HIV-1 protease
M L Moore, W M Bryan, S A Fakhoury, et al.
Bioorganic & Medicinal Chemistry
|
October 9, 2022
The design of protozoan phosphoribosyltransferase inhibitors containing non-charged phosphate mimic residues
Sinan Gai, Kajitha Suthagar, Karl J Shaffer, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
D M Lambert, S R Petteway, C E McDanal, et al.
Page
of 21